These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 375952)

  • 21. [Clinical observations on the treatment of ischemic cardiac disease with a calcium antagonist: nifedipine].
    Bufalini AA; Bargero G; Botta M; Marzani MC; Montalenti P; Navazzotti R; Piccolini E; Marzani PC
    Arch Sci Med (Torino); 1980; 137(4):715-24. PubMed ID: 7247695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of a field trial of the coronary drug Adalat (BAY a 1040)].
    Dünschede HB; Grundei P
    Med Welt; 1975 Oct; 26(40):1847-50. PubMed ID: 1102835
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of nifedipine on coronary blood flow and coronary resistance during cold pressor test and isometric exercise in patients with coronary artery disease.
    de Servi S; Mussini A; Specchia G; Bramucci E; Gavazzi A; Falcone C; Ardissino D; Guagliumi G; Bobba P
    Eur Heart J; 1980 Dec; 1(Suppl B):43-7. PubMed ID: 7348215
    [No Abstract]   [Full Text] [Related]  

  • 24. [Angina pectoris by effort. Effect of Bay a 1040].
    Arce Gómez E; Aspe y Rosas J; Alcocer Diaz L
    Prensa Med Mex; 1976; 41(1-2):56-62. PubMed ID: 778824
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of intravenous nifedipine administration on coronary occlusion during coronary angioplasty on ischemia tolerance and collateral function].
    Ischinger T; Coppenrath K; Antoni D; Nowak F; Delius W
    Z Kardiol; 1990 Mar; 79(3):166-75. PubMed ID: 2191507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
    Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
    [No Abstract]   [Full Text] [Related]  

  • 27. Double-blind trial of nifedipine in angina patients with normal coronary arteries.
    Pitcher D; Sowton E
    Pharmatherapeutica; 1981; 3(1):6-13. PubMed ID: 6798584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
    Strasser R; Klepzig H
    MMW Munch Med Wochenschr; 1981 Aug; 123(35):1303-6. PubMed ID: 6793850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analogy of response to acute and chronic nifedipine therapy in hypertensive and non-hypertensive patients].
    Longhini C; Pinelli G; Portaluppi F; Toselli T; Ravenna F; Manini GL; Dominici P; Pedrielli F
    Boll Soc Ital Cardiol; 1979; 24(7):779-82. PubMed ID: 554666
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation and comparison of five antianginal treatments by means of a bicycle ergometer exercise test (author's transl)].
    Borgioni L; Medugno G; Riavez R; Scardi S; Camerini F
    G Ital Cardiol; 1976; 6(6):994-1007. PubMed ID: 798709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifedipine for angina and acute myocardial ischaemia.
    Hugenholtz PG; Verdouw PD; de Jong JW; Serruys PW
    Postgrad Med J; 1983; 59 Suppl 2():40-58. PubMed ID: 6351043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute effects of nifedipine and verapamil on arterial pressure, at rest and during and after exercise in hypertensive patients].
    Novo S; Riolo F; Pinto A; Davì G; Botindari C
    Boll Soc Ital Cardiol; 1980; 25(2):157-63. PubMed ID: 7236440
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of nifedipine on pacing-induced angina in subjects with ischemic cardiopathy].
    Arena G; Custurone D; Tedesco V; Lopresti D
    Boll Soc Ital Cardiol; 1978; 23(8):1368-73. PubMed ID: 549622
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina.
    De Ponti C; De Biase AM; Pirelli S; Cataldo G; Salvadé P; Lanocita M; Carù B
    Cardiology; 1981; 68 Suppl 2():195-9. PubMed ID: 7032697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Varying response to nifedipine during treatment of stable exertional angina pectoris: results of a double-blind, randomized, cross-over, placebo-controlled study (author's transl)].
    Brügmann U; Blasini R; Goebel G; Mannes A; Dirschinger J; Rudolph W
    Herz; 1982 Apr; 7(2):117-25. PubMed ID: 7044932
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-angina effectiveness of the calcium antagonist nifedipine in relation to coronary involvement].
    Schulz W; Jost S; Kaltenbach M; Kober G
    Z Kardiol; 1983 Nov; 72(11):657-64. PubMed ID: 6362245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined evaluation of the therapeutic activity of nifedipine in coronary insufficiency alone and with hypertension].
    Di Marco G; De Simone G; Cionci M; Patriarchi F; Spadano E
    Boll Soc Ital Cardiol; 1980; 25(3):231-44. PubMed ID: 7284128
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects and duration of the action of nifedipine tablets (20 mg). Ergometric evaluation in double-blind studies with a placebo].
    Gibelli G; Carnovali M; Orvieni C; Colombo G; Castelli D; De Vita C
    Minerva Cardioangiol; 1982; 30(7-8):387-94. PubMed ID: 6752751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.